Pearls and Pitfalls for Launching into Clinical Research
You’re invited to join the Clinical TMS Society for this installment of our Grand Round Webinar Series: Pearls and Pitfalls for Launching into Clinical Research
1. Why its important to conduct research properly
2. How we chose topics to be covered
3. IRB process
4. Building a database
6. How to prepare an abstract
7. How to determine your research question
Date of Release: October 9, 2020
Date of Expiration: October 8, 2022
Cost: Members: $25 | Non-members $50 | Student Members FREE
SPEAKERS: F. Andrew Kozel, MD, MSCR, Andrew Leuchter, MD, Paul Croarkin, DO, MS, Angela Leah Phillips, LICSW, PhD
F. Andrew Kozel, MD, MSCR - Dr. Kozel is the Director of the TMS Clinic and Staff Psychiatrist in Mental Health and Behavioral Sciences (MH&BS) and Associate Investigator in the HSR&D Center of Innovation on Disability and Rehabilitation Research (CINDRR) at the James A. Haley Veteran's hospital, as well as Associate Professor, Department of Psychiatry and Behavioral Sciences, University of South Florida. Dr. Kozel's research uses brain imaging and brain stimulation to better understand and treat neuropsychiatric disorders with the focus of improving the lives of patients with these disorders.
Andrew F. Leuchter, MD, is a Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior, Executive Vice Chair of the Department of Psychiatry and Biobehavioral Sciences, and Associate Director of the Semel Institute. He also is Director of the Neuromodulation Division at the Semel Institute. Dr. Leuchter is a graduate of Stanford University and the Baylor College of Medicine who joined the UCLA faculty in 1986.
An expert on the treatment of mood disorders, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. This is one of the largest academic TMS program in the country, which performs more than 6,000 treatments each year for patients with depression, pain, Obsessive-Compulsive Disorder, tinnitus, and other neuropsychiatric illness. He performs research to enhance TMS treatment effectiveness, as well as clinical trials to improve treatment of depression, Post-Traumatic Stress Disorder (PTSD), and Attention-Deficit/Hyperactivity Disorder (ADHD). Dr. Leuchter’s research aims to develop novel treatment strategies and uses brain-imaging techniques, such as quantitative electroencephalography (qEEG) and magnetic resonance imaging (MRI) to examine brain function and predict which treatments are most likely to benefit individual patients.
Dr. Leuchter has authored over 150 scientific articles on topics including neuromodulation for the treatment of depression, EEG biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action. He teaches internationally on TMS and other neuromodulation methods, and received the 2019 Outstanding Research Mentor Award from the Semel Institute.
Paul Croarkin, DO, MS' research program focuses on adapting and innovating brain stimulation interventions in children and adolescents. This includes biomarker work to optimize diagnostic practices and the delivery of brain based interventions such as transcranial magnetic stimulation. A central theme focuses on the role of gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems in early-onset mood disorders with the goal of informing safer and more effective biologic treatments. Dr. Croarkin is a professor of psychiatry in the Mayo Clinic College of Medicine.
Angela Phillips, LICSW, PhD currently has a dual postdoctoral role with the Stanford Brain Stimulation Lab, and the VA, Palo Alto, CA, USA. She obtained her BA from the University of North Carolina in Clinical Psychology, followed by her MSW and clinical licensure in Mental Health Practice, and PhD in Nursing Science, from the University of Washington. Angela has worked across inpatient and outpatient clinical psychiatry for over a decade with research interests focusing on neuromodulatory psychiatric and mental health interventions, including novel non-invasive brain stimulation methods, and combined psychotherapeutic interventions for complex neurological and neuropsychiatric disorders.
Acknowledgement of Financial and/or In-Kind Commercial Support
No financial or in-kind commercial support was received for this educational activity.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Questions? Email Certificate@AmedcoEmail.com
|Webinar Registration | Non-Member||$50.00|
Grand Rounds Webinar